Hematopoietic cell counts (HSC (for Hematopoietic stem cell))

“Hematopoietic cell counts” refers collectively to laboratory measurements quantifying various mature blood cells—including red blood cells, white blood cells (and their subtypes), and platelets—in peripheral circulation. These values reflect the output of the bone marrow’s hematopoiesis process driven by multipotent **hematopoietic stem cells**, which reside primarily in bone marrow tissue. While critical for diagnosis and management across oncology, immunology, infectious diseases, and general medicine—as well as being key safety endpoints—they do *not* represent discrete molecular targets suitable for drug development or mechanistic study on their own.[1][3][4] If you require information about an actual therapeutic target involved in regulating “hematopoiesis” or “cell production,” consider specifying entities such as “Granulocyte colony-stimulating factor receptor,” “Erythropoetin receptor,” or simply “Hematopoietic stem/progenitor cells.”

Other names

Blood countComplete blood count (CBC)Peripheral blood countsWhite blood cell count (WBC)red blood cell count (RBC)platelet count

Not applicable directly—see above. Drugs that affect hematologic parameters act via: - Stimulating proliferation/differentiation of progenitor cells in bone marrow - Suppressing immune-mediated destruction - Direct cytotoxicity against dividing cells